Evidence that Activation of the Hypothalamo-Pituitary-Adrenal Axis by Electrical Stimulation of the Noradrenergic A1 Group Is Not Mediated by Noradrenaline

1995 ◽  
Vol 62 (1) ◽  
pp. 2-12 ◽  
Author(s):  
Sarah E. Gartside ◽  
Marie-Françoise Suaud-Chagny ◽  
Marcel Tappaz
1981 ◽  
Vol 240 (6) ◽  
pp. E689-E693 ◽  
Author(s):  
M. Karteszi ◽  
E. Stark ◽  
G. Rappay ◽  
F. A. Laszlo ◽  
G. B. Makara

Electrical stimulation of the neural lobe of the pituitary resulted in an increase of corticosterone secretion in both normal and Brattleboro rats. Bioassaying the corticoliberin (CRF) activity of stalk-median eminence and neural lobe extracts obtained from normal and Brattleboro rats revealed that the endogenous vasopressin was not a prerequisite of ACTH-releasing potency. Arginine-8-vasopressin failed to potentiate the CRF activity of the different extracts. These data suggest that a nonvasopressin substance(s) with CRF activity can be released from the neurohypophysis of the rat, and it may contribute to activating the pituitary-adrenal axis under certain experimental conditions.


1986 ◽  
Vol 112 (1) ◽  
pp. 28-34 ◽  
Author(s):  
Gabriel Dickstein ◽  
Michal Lahav ◽  
Zila Shen Orr

Abstract. One dose of metyrapone (1.5 g) administered at 06.00 h, with subsequent measurement of 11-deoxycortisol and 17-hydroxycorticosteroid (17-OHCS) levels in plasma at 12.00 and 14.00 h, allowed accurate assessment of the pituitary-adrenal reserve. Normal response was defined as achieving a serum 17-OHCS level of more than 10.0 μg/100 ml and a 11-deoxycortisol level of more than 6.0 μg/100 ml at either 12.00 or 14.00 h. These criteria are based on a group of 18 persons with normal pituitary-adrenal axis, and 86 additional cases responded in this normal range. In this group of 104 subjects, 11-deoxycortisol levels rose to 9.2 ± 3.5 μg/100 ml at noon and 17-OHCS levels to 15.4 ± 4.7 μg/100 ml at 14.00 h. Post-metyrapone 17-OHCS levels were significantly higher than normal cortisol levels at these times (P < 0.001) and than those observed at 08.00 h on the day of the test, demonstrating stimulation of adrenal corticoid production in addition to blockade of cortisol production by metyrapone. Thirty-one patients found to suffer from secondary adrenal failure showed impaired response. All these patients had limited pituitary-adrenal reserve, either proven by other pituitary-adrenal tests or implicated by severe pituitary disease.


Life Sciences ◽  
1989 ◽  
Vol 44 (2) ◽  
pp. 143-147 ◽  
Author(s):  
Robert N. Pechnick ◽  
Robert George ◽  
Russell E. Poland

Pituitary ◽  
2005 ◽  
Vol 8 (2) ◽  
pp. 115-122 ◽  
Author(s):  
Eliza B Geer ◽  
Rita E Landman ◽  
Sharon L Wardlaw ◽  
Irene M Conwell ◽  
Pamela U. Freda

Sign in / Sign up

Export Citation Format

Share Document